Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Kogner

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Stem Cell Research|January 4, 2019
Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutationAna Marin Navarro, Kelly Day, Per Kogner, et al.
International Journal of Oncology|January 5, 2023
Identification of recurrent 3q13.31 chromosomal rearrangement indicates <i>LSAMP</i> as a tumor suppressor gene in neuroblastomaAngela Martinez-Monleon, Jennie Gaarder, Anna Djos, et al.
International Journal of Cancer|February 14, 2003
The synthetic retinoid RO 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivoFrida Ponthan, John Inge Johnsen, Lena Klevenvall, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2005
Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biologyFrida Abel, Rose-Marie Sjöberg, Staffan Nilsson, et al.
Journal of Pediatric Hematology/Oncology|November 8, 2008
The influence of pediatric cancer diagnosis and illness complication factors on parental distressEmma Hovén, Malin Anclair, Ulf Samuelsson, et al.
International Journal of Cancer|September 25, 2008
mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosisCatarina Träger, Asa Vernby, Anita Kullman, et al.
Journal of the Endocrine Society|February 8, 2024
Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in <i>Ex Vivo</i> Cultured Rat BonesLilly Velentza, Malin Wickström, Per Kogner, et al.
Cell Research|February 13, 2008
Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cellsLena-Maria Carlson, Sven Påhlman, Anna De Geer, et al.
Pigment Cell Research|July 15, 2004
Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cellsBertil Kågedal, Anita Kullman, Liselotte Lenner, et al.
Scientific Reports|May 17, 2023
Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growthLilly Velentza, Malin Wickström, Per Kogner, et al.
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Stem Cell Research|January 4, 2019
Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutationAna Marin Navarro, Kelly Day, Per Kogner, et al.
International Journal of Oncology|January 5, 2023
Identification of recurrent 3q13.31 chromosomal rearrangement indicates <i>LSAMP</i> as a tumor suppressor gene in neuroblastomaAngela Martinez-Monleon, Jennie Gaarder, Anna Djos, et al.
International Journal of Cancer|February 14, 2003
The synthetic retinoid RO 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivoFrida Ponthan, John Inge Johnsen, Lena Klevenvall, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2005
Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biologyFrida Abel, Rose-Marie Sjöberg, Staffan Nilsson, et al.
Journal of Pediatric Hematology/Oncology|November 8, 2008
The influence of pediatric cancer diagnosis and illness complication factors on parental distressEmma Hovén, Malin Anclair, Ulf Samuelsson, et al.
International Journal of Cancer|September 25, 2008
mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosisCatarina Träger, Asa Vernby, Anita Kullman, et al.
Journal of the Endocrine Society|February 8, 2024
Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in <i>Ex Vivo</i> Cultured Rat BonesLilly Velentza, Malin Wickström, Per Kogner, et al.
Cell Research|February 13, 2008
Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cellsLena-Maria Carlson, Sven Påhlman, Anna De Geer, et al.
Pigment Cell Research|July 15, 2004
Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cellsBertil Kågedal, Anita Kullman, Liselotte Lenner, et al.
Scientific Reports|May 17, 2023
Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growthLilly Velentza, Malin Wickström, Per Kogner, et al.
Pageof 17